Cash Flow Statement
Growth Metrics

Orthofix Medical (OFIX) Long-Term Deferred Tax (2016 - 2022)

Orthofix Medical has reported Long-Term Deferred Tax over the past 13 years, most recently at $1.5 million for Q3 2022.

  • For the quarter ending Q3 2022, Long-Term Deferred Tax fell 93.21% year-over-year to $1.5 million, compared with a TTM value of $1.5 million through Sep 2022, down 93.21%, and an annual FY2021 reading of $1.8 million, down 92.93% over the prior year.
  • Long-Term Deferred Tax came in at $1.5 million for Q3 2022, up from $1.5 million in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $39.6 million in Q3 2019 to a low of $1.5 million in Q2 2022.
  • Median Long-Term Deferred Tax over the past 5 years was $30.6 million (2018), compared with a mean of $25.8 million.
  • The sharpest move saw Long-Term Deferred Tax soared 42.52% in 2018, then crashed 93.21% in 2022.
  • Over 5 years, Long-Term Deferred Tax stood at $33.2 million in 2018, then rose by 5.68% to $35.1 million in 2019, then decreased by 28.69% to $25.0 million in 2020, then crashed by 92.93% to $1.8 million in 2021, then fell by 12.82% to $1.5 million in 2022.
  • Per Business Quant, the three most recent readings for OFIX's Long-Term Deferred Tax are $1.5 million (Q3 2022), $1.5 million (Q2 2022), and $1.9 million (Q1 2022).